CytoSorbents Corporation

The US Food and Drug Administration has doled out 27 emergency use authorizations (EUA) since the start of the month, and eight of those have been since 10 April. While there are indications social

Company Changes ADAMS , Derek, PhD To: bluebird bio Inc. , Chief Technology & Mfg. Officer (March) From: Evelo Biosciences, SVP, CMC Phone: 339-499-9300 ARBET-ENGELS , Christophe, MD, PhD To:

Derived from Strategic Transactions , Informa’s premium source for tracking life-sciences deal activity, this new bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partne

Feasibility Trials Of Two Xeltis' Biosorbable Heart Devices Begin Five pediatric patients treated with Xeltis AG 's bioabsorbable cardiovascular conduit in the extracardiac total cavopulmonary conn